Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: A counterregulatory mechanism that restrains the immune response

Journal of Experimental Medicine

Volumn 185, Issue 10, 1997, Pages 1759-1768

  Zhang, Minghuang ^b   Caragine, Theresa ^b   Wang, Haichao ^a,b   Cohen, Pamela S ^b   Botchkina, Galina ^b   Soda, Kuniyasu ^b   Bianchi, Marina ^b   Ulrich, Peter ^b   Cerami, Anthony ^b   Sherry, Barbara ^b   Tracey, Kevin J ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOGENIC AMINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; SPERMINE; TUMOR NECROSIS FACTOR;

ARTICLE; CONTROLLED STUDY; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION; INFLAMMATION; INJURY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; CARRAGEENAN; CELL LINE; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMEOSTASIS; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; KINETICS; LIPOPOLYSACCHARIDES; MACROPHAGE INFLAMMATORY PROTEIN-1; MACROPHAGES; MICE; MICE, INBRED C3H; MONOCYTES; SPERMINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030965838     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.10.1759     Document Type: Article

References (57)

1. Titus, R.G., B. Sherry, and A. Cerami. 1989. Tumor necrosis factor plays a protective role in experimental murine cutaneous Leishmaniasis. J. Exp. Med. 170:2097-2104.
2. Pfeffer, K., T. Matsuyama, T.M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P.S. Ohashi, M. Kronke, and T.W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73: 457-467.
3. Tracey, K.J., B. Beutler, S.F. Lowry, J. Merryweather, S. Wolpe, I.W. Milsark, R.J. Hariri, T.F. Fahey, III, A. Zentella, J.D. Albert et al. 1986. Shock and tissue injury induced by recombinant human cachectin. Science (Wash. DC). 234:470-474.
4. Tracey, K.J., Y. Fong, D.G. Hesse, K.R. Manogue, A.T. Lee, G.C. Kuo, S.F. Lowry, and A. Cerami. 1987. Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (Lond.). 330:662-664.
5. Tracey, K.J. 1997. Tumor necrosis factor. In Cytokines in Health and Disease. D.G. Remick and J.S. Friedland, editors. Marcel Dekker, Inc., New York. In press.
6. Gonzalez, J.C., D.C. Johnson, D.C. Morrison, M.A. Freudenberg, C. Galanos, and R. Silverstein. 1993. Endogenous and exogenous glucocorticoids have different roles in modulating endotoxin lethality in D-galactosamine-sensitized mice. Infect. Immun. 61:970-974.
7. Beutler, B., N. Krochin, I.W. Milsark, C. Luedke, and A. Cerami. 1986. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science (Wash. DC). 232:977-980.
8. Tsunawaki, S., M. Sporn, A. Ding, and C.F. Nathan. 1988. Deactivation of macrophages by transforming growth factor-beta. Nature (Lond.). 334:260-262.
9. Donnelly, R.P., S.L. Freeman, and M.P. Hayes. 1995. Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-α in human monocytes. J. Immunol. 155: 1420-1427.
10. Frankenberger, M., H. Pechumer, and H.W.L. Ziegler-Heitbrok. 1995. Interleukin-10 is upregulated in LPS tolerance. J. Inflammation. 45:56-63.
11. Randow, F., U. Syrbe, C. Meisel, D. Drausch, H. Zuckermann, C. Platzer, and H.D. Volk. 1995. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor β. J. Exp. Med. 181:1887-1892.
12. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of TNF and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547-550.
13. Lehmmann, V., B. Benninghoff, and W. Droge. 1988. TNF induced activation of peritoneal macrophages is regulated by prostaglandin E2 and cAMP. J. Immunol. 141:587-591.
14. Sinha, B., J. Semmler, T. Eisenhut, A. Eigler, and S. Endres. 1995. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphage accumulation by combination of phosphodiesterase inhibitors and prostanoids. Eur. J. Immunol. 25:147-153.
15. Bianchi, M., P. Ulrich, O. Bloom, M. Meistrell, III G.A. Zimmerman, H. Schmidtmayerova, M. Bukrinsky, T. Donnelly, R. Bucala, B. Sherry et al. An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammatory and endotoxin lethality. Mol. Med. 1:254-266.
16. Bianchi, M., O. Bloom, T. Raabe, P.S. Cohen, J. Chesney, B. Sherry, H. Schmidtmayerova, T. Calandra, X. Zhang, M. Bukrinsky et al. 1996. Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J. Exp. Med. 83:927-936.
17. Cohen, P.S., H. Nakshaatri, J. Dennis, T. Caragine, M. Bianchi, A. Cerami, and K.J. Tracey. 1996. CNI-1493 Inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proc Natl. Acad Sci. USA. 93:3967-3971.
18. Seiler, N., and C.L. Atanassov. 1994. The natural polyamines and the immune system. Prog. Drug Res. 43:87-141.
19. Southan, G.J., C. Szabo, and C. Thiemermann. 1994. Inhibition of the induction of nitric oxide synthase by spermine is modulated by aldehyde dehydrogenase. Biochem. Biophys. Res. Comm. 203:1638-1644.
20. Szabo, C., G.J. Southan, C. Thiemermann, and J.R. Vane. 1992. Inhibitors of polyamine biosynthesis block tumor necrosis factor-induced activation of macrophages. Cancer Res. 52:1891-1894.
21. Ferrante, A. 1985. Inhibition of human neutrophil locomotion by the polyamine oxidase-polyamine system. Immunology. 54:785-790.
22. Quan, C.P., C. Roux, J. Pillot, and J.P. Bouvet. 1990. Delineation between T and B suppressive molecules from human seminal plasma: II. Spermine is the major suppressor of T-lymphocytes in vitro. Am. J. Reprod. Immunol. 22:64-69.
23. Morgan, D.M.L. 1987. Polyamines. Essays Biochem. 23.82-115.
24. Hempel, K.H., L.A. Fernandez, and R.H. Persellin. 1983. Effect of pregnancy sera on isolated lysosomes. Nature (Lond.). 225:32-35.
25. Lewis, D.A., R.B. Capstick, and R. Best. 1976. The control of rheumatic diseases by endogenous protein. Biochem. Pharmacol. 25:1435-1436.
26. Persellin, R.A. 1972. Lysosome stabilization by adjuvant arthritis serum. Arthritis Rheum. 15:144-152.
27. Rinandi, T.H. 1956. Recovery of an anti-inflammatory fraction from inflammatory exudate. Indian J. Med. Res. 44:144.
28. Robinson, B.V. and J.M. Robson. 1964. Production of an anti-inflammatory substance at a site of inflammation. Br. J. Pharmacol. 23:420.
29. Sampaio, E.P., E.N. Sarno, R. Galilly, Z.A. Cohn, and G. Kaplan. 1991. Thalidomide selectively inhibits TNFα production by stimulated human moncytes. J. Exp. Med. 173: 699-703.
30. Sherry, B., G. Alava, K.J. Tracey, J. Martiney, A. Cerami, and A.F.G. Slater. 1995. The malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1α, and MIP-1β) in vitro, and altered thermoregulation in vivo. J. Inflammation 45:85-96.
31. Han, J., G. Huez, and B. Beutler. 1991. Interactive effects of the tumor necrosis factor promoter and 3′-untranslated regions. J. Immunol. 146:1843-1848.
32. Szabo, C., G.J. Southan, E. Wood, C. Thiemermann, and J.R. Vanne. 1994. Inhibition by spermine of the induction of nitric oxide synthase in J774.2 macrophages: requirement of a serum factor. Br. J. Pharmacol. 110:355-356.
33. Houen, G., K. Bock, and A.L. Jensen. 1994. HPLC and NMR investigation of the serum amine oxidase catalyzed oxidation of polyamines. Acta. Chem. Scand. 48:52-60.
34. Otterness, I.V. and P.F. Moore. 1988. Carrageenan foot edema test. Meth. Enzymol. 162:320-327.
35. Ianaro, A., C.A. O'Donnell, M. Di Rosa, and F.Y. Liew. 1994. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced edema in mice. Immunology. 82:370-375.
36. Hirsch, J.G. and R.J. Dubos. 1952. The effect of spermine on tubercle bacilli. J. Exp. Med. 95:191-208.
37. Dinarello, C.A. 1996. Biologic basis for interleukin-1 in disease. Blood. 87:2095-2147.
38. Wolpe, S.D., G. Davatelis, B. Sherry, B. Beutler, D.G. Hesse, H.T. Nguyen, L.L. Moldawer, C.F. Nathan, S.F. Lowry, and A. Cerami. 1987. Macrophages secrete a novel heparin-binding protein with inflammatory properties. J Exp. Med. 167:570-581.
39. Wolpe, S.D., B. Sherry, D. Juers, G. Davatelis, R.W. Yurt, and A. Cerami. 1989. Identification and characterization of macrophage inflammatory protein 2. Proc. Natl. Acad. Sci. USA. 86:612-616.
40. Fong, Y., K.J. Tracey, L.L. Moldawer, D.G. Hesse, K.R. Manogue, J.S. Kenney, A.T. Lee, G.C. Kuo, A.C. Allison, S.F. Lowry et al. Antibodies to cachectin/TNF reduce interleukin-1-beta and interleukin-6 appearance during lethal bacteremia. J. Exp. Med. 170:1627-1633.
41. Ding, A., C.F. Nathan, J. Graycar, R. Derynck, D.J. Stuehr, and S. Srimal. 1988. Macrophage deactivating factor and transforming growth factors-B1, -B2, and B3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J. Immunol. 145:940-944.
42. Oswald, I.P., T.A. Wynn, A. Sher, and S.L. James. 1993. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor α required as a costimulatory factor for interferon γ-induced activation. Proc. Natl. Acad. Sci. USA. 89:8676-8680.
43. Hart, P.H., G.A. Whitty, D.S. Piccoli, and J.A. Hamilton. 1989. Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes. Immunology. 66:376-383.
44. Kurihara, H., S. Matsuzaki, H. Yamazaki, T. Tsukahara, and M. Tamura. 1993. Relation between tissue polyamine levels and malignancy in primary brain tumors. Neurosurgery. 32: 372-375.
45. Susuki, O., T. Matsumoto, and Y. Katsumata. 1984. Determination of polyamine oxidase activities in human tissues. Experementia. 40:838-839.
46. Seiler, N., F.N. Bolkenius, and B. Knodgen. 1985. The influence of catabolic reactions on polyamine excretion. Biochem. J. 225:219-226.
47. Cipolla, B., F. Guille, J.P. Moulinoux, V. Quemener, F. Staerman, L. Corbel, and B. Lobel. 1993. Polyamines and prostatic carcinoma: clinical and therapeutic implications. Eur. Urol. 24:124-131.
48. Parchment, R.E. and G.B. Pierce. 1989. Polyamine oxidation, programmed cell death, and regulation of melanoma in the murine embryonic limb. Cancer Res. 49:6680-6686.
49. Gramzinski, R.A., R.E. Parchment, and G.B. Pierce. 1990. Evidence linking programmed cell death in the blastocyst to polyamine oxidation. Differentiation. 43:59-65.
50. Romero, R., K.R. Manogue, M.D. Mitchell, Y.K. Wu, E. Oyarzun, J.C. Hobbins, and A. Cerami. 1989. Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am. J. Obstet. Gynecol. 161:336-341.
51. Flescher, E., T.L. Bowlin, and N. Talal. 1989. Polyamine oxidation down-regulates IL-2 production by human peripheral blood mononuclear cells. J. Immunol. 142:907-912.
52. Leudke, C.E., and A. Cerami. 1990. Interferon-gamma overcomes glucocorticoid suppression of cachectin/tumor necrosis factor biosynthesis by murine macrophages. J. Clin. Invest. 86:1234-1240.
53. Scheinman, R.I., P.C. Cogswell, A.K. Lofquist, and A.S. Baldwin, Jr. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science (Wash. DC). 270:283-286.
54. 2+-ATPase.J. Cell. Physiol. 157:493-501.
55. Ding, A.H., E. Sanchez, S. Srimal, and C.F. Nathan. 1989. Macrophages rapidly internalize their tumor necrosis factor receptors in response to bacterial lipopolysaccharide. J. Biol. Chem. 264:3924-3929.
56. Baydoun, A.R., R.G. Bogle, J.D. Pearson, and G.E. Mann. 1994. Discrimination between citrulline and arginine transport in activated murine macrophages: inefficient synthesis of NO from recycling of citrulline to arginine. Br. J. Pharmacol. 112:487-492.
57. Walters J.D., and M.S. Wojcik. 1994. Polyamine transport in human promyelocytic leukemia cells and polymorphonuclear leukocytes. Leuk. Res. 18:703-708.